CPhT CONNECT™ Magazine - Volume 5 Issue 2

CONTINUING EDUCATION

blinatumomab

Antineoplastic agents "Vasodilating agents. Vasodilating agents, miscellaneous" Antineoplastic agents

Yes

No

bosentan

No

Yes

bosutinib

No No No No No No No

Yes Yes

cabergoline

Nonergot- derivative dopamine receptor agonists

cabozantinib

Antineoplastic agents

Yes

carbamazepine

Anticonvulsants, miscellaneous; anti- manic agents

No

carfilzomib ceritinib cetrorelix

Antineoplastic agents Antineoplastic agents Antigonadotropins

Yes Yes Yes Yes Yes Yes Yes Yes Yes

choriogonadotropin

Gonadotropins Benzodiazepines

Yes

clobazam clomiphene clonazepam cobimetinib colchicine crizotinib dabrafenib deferiprone

No No No No No No No No No

Estrogen agonist-antagonists

Benzodiazepines

Antineoplastic agents

Antigout agent

Antineoplastic agents Antineoplastic agents Heavy metal antagonists "antigonadotropins. Antineoplastic agents"

No No No

degarelix

Yes

dihydroergotamine

Non-selective alpha-adrenergic blocking agents; antimigraine agents, miscella- neous

No

Yes

dinoprostone

Oxytocics

No No

Yes Yes

divalproex

Anticonvulsants, miscellaneous; an- timanic agents; antimigraine agents, miscellaneous

dronedarone

Class III antiarrhythmics

No No No No No No No No No No No

Yes

entecavir

"Nucleosides and nucleotides"

No

enzalutamide

Antineoplastic agents Antineoplastic agents

Yes Yes Yes

erlotinib

eslicarbazepine

"Anticonvulsants, miscellaneous"

dutasteride

Alpha-reductase inhibitors

Yes

estradiol

Estrogens; bone resorption inhibitors

No No

estropipate exemestane

Estrogens

"Antiestrogens. Antineoplastic agents"

Yes

exenatide finasteride

Incretin mimetics

No

Skin and mucous membrane agents, miscellaneous; 5-alpha-reductase inhibitors

Yes

CPhT CONNECT www.cphtconnect.com

41

Made with FlippingBook - PDF hosting